Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 25:11:2079.
doi: 10.3389/fmicb.2020.02079. eCollection 2020.

Respiratory Microbial Co-infection With SARS-CoV-2

Bill W Massey  1   2 , Karuna Jayathilake  3 , Herbert Y Meltzer  3
Affiliations

Respiratory Microbial Co-infection With SARS-CoV-2

Bill W Massey et al. Front Microbiol. .

Abstract

Co-infection with additional pathogens is a well-known feature of pandemics. We determined the prevalence and type of a wide variety of respiratory pathogens in 12,075 United States subjects tested for SARS-CoV-2 infection in March and April 2020. Infections with other respiratory pathogens, which on their own produce at least some SARS-CoV-2 symptoms including mortality, were present in both SARS-CoV-2 + and SARS-CoV-2- subjects. Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%) (p < 0.0001). Among the co-pathogens present in both subject groups were K. pneumoniae and M. catarrhalis which can produce serious respiratory illness on their own, Advanced age and nursing home status were associated with higher SARS-CoV-2 + and co-infection rates. Testing for the presence of co-pathogens going forward will assist in the diagnosis and optimal treatment of suspected SARS-CoV-2 respiratory infections in the current pandemic.

Keywords: COVID-19; K. pneumoniae; M. catarrhalis; SARS-CoV-2; age; nursing home; race; respiratory co-infection.

PubMed Disclaimer

References

    1. Cox M. J., Loman N., Bogaert D., O’Grady J. (2020). Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microb. 1:e11 10.1016/s2666-5247(20)30009-4 - DOI - PMC - PubMed
    1. D’Ardes D., Boccatonda A., Schiavone C., Santilli F., Guagnano M. T., Bucci M., et al. (2020). A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of COVID-19. Eur. J. Case Rep. Intern. Med. 7:1652 10.12890/2020_001652 - DOI - PMC - PubMed
    1. Gao J., Tian Z., Yang X. (2020). Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends 14 72–73. 10.5582/bst.2020.01047 - DOI - PubMed
    1. Henig O., Kaye K. S. (2017). Bacterial pneumonia in older adults. Infect. Dis. Clin. North Am. 31 689–713. 10.1016/j.idc.2017.07.015 - DOI - PMC - PubMed
    1. Jensen I. J., Sjaastad F. V., Griffith T. S., Badovinac V. P. (2018). Sepsis-induced T cell immunoparalysis: the ins and outs of impaired T cell immunity. J. Immunol. 200 1543–1553. - PMC - PubMed